Erste Asset Management GmbH
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2024532
VIENNA, C4
Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$44,201,961
+$4,026,900 QoQ
Shares Held
57,209
+9.9% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Erste Asset Management GmbH holds $563,481,319 across 72 Biotechnology names. REGN ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,704,900 | $91,506,767 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
160,210 | $83,865,128 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,968,945 | $64,604,243 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
57,209 | $44,201,961 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,958 | $41,062,925 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
210,000 | $19,399,800 | |
| 7 | REPL |
Replimune Group, Inc.
|
2,120,000 | $16,218,000 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
446,000 | $14,521,760 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,201,961 | 57,209 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $40,175,061 | 52,049 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $27,402,789 | 48,736 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $28,033,425 | 53,397 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $23,487,439 | 37,033 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,765,310 | 40,382 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $42,721,342 | 40,639 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $40,814,647 | 38,833 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $40,374,530 | 41,948 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $35,904,495 | 40,880 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $31,659,271 | 38,470 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $28,635,974 | 39,853 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $32,406,664 | 39,440 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $23,194,460 | 32,148 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $23,514,577 | 34,135 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $19,671,624 | 33,278 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $22,489,822 | 32,201 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $21,001,829 | 33,256 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $21,163,144 | 34,970 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $17,577,253 | 31,470 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $15,670,396 | 33,120 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $15,879,825 | 32,870 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $19,967,352 | 35,670 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $22,451,400 | 36,000 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $4,638,755 | 9,500 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||